Navigation Links
VIVUS Reports Second Quarter 2009 Financial Results
Date:8/11/2009

MOUNTAIN VIEW, Calif., Aug. 11 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its financial results for the second quarter ended June 30, 2009.

Second Quarter Results

Net loss for the second quarter of 2009 was $13.2 million, or $0.19 per share, as compared to net income of $3.6 million, or $0.06 per share, for the second quarter of 2008. The net loss in the second quarter of 2009 as compared to the net income in the second quarter of 2008 is primarily due to a decrease in license and other revenue as a result of the last portion of K-V Pharmaceutical ("K-V") deferred license revenue being recognized in the second quarter of 2009, and increased operating expenses. The increase in operating expenses, as compared to the second quarter of 2008, was primarily attributable to spending related to our phase 3 clinical trials of avanafil, our investigational product candidate for the treatment of erectile dysfunction. Spending on Qnexa, our investigational product for obesity, was consistent quarter over quarter.

Total revenue for the second quarter of 2009 was $14.7 million, as compared to $25.3 million for the second quarter of 2008. Product revenues from the sale of MUSE in the second quarter of 2009 were $4.1 million, as compared to $4.2 million in the second quarter of 2008. License and other revenue of $10.6 million and $21 million in the second quarters of 2009 and 2008, respectively, primarily relates to the sale in 2007 of Evamist to K-V. All of the deferred revenue related to the sale of Evamist has now been recognized. Since we had received the $150 million in cash from the sale of Evamist and we had no related contingencies, th
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
2. Mesa Labs Reports Higher First Quarter Earnings
3. Physician Owned and Operated Hospitals Get Top Rankings From Consumer Reports, but They Remain on the Healthcare Reform Chopping Block
4. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
5. Winner Medical Reports Third Quarter Fiscal 2009 Results
6. Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
7. DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results
8. Cornerstone Therapeutics Reports Second Quarter and First Half 2009 Financial Results
9. Cardiac Science Reports Q2 Revenue; Resumes AED Shipments
10. PAREXEL International Reports Fourth Quarter and Fiscal Year 2009 Results
11. Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Newswire-USNewswire/ -- Samuel Gladding is no Scro...ans to be "happy" during the holidays. As a licens...ly counseling and chair of the Department of Couns...earch shows that it is the pressure to be happy th...ng the holidays. ,, That,s why he,s challenging...
(Date:11/20/2009)...with chronic kidney disease often fail to detect h...ncreasing a child,s risk for serious heart problem...en,s Center and other institutions. A report of th...an Society of Nephrology. , Researchers compar...ular doctor visits to readings obtained via a spec...
(Date:11/20/2009)... with seasonal flu , , FRIDAY, Nov. 20 ...ting that children with asthma are more likely to .... , "Asthma has been identified as a significan...luenza, present in 21 percent to 30 percent in the... researchers from the Hospital for Sick Children i...
(Date:11/20/2009)...0 Omnicell, Inc. (Nasdaq...o acute healthcare facilities, announced today the...ffray Healthcare Conference at the New York Palac... Randall A. Lipps, founder, chairman, president &..., Date: Tuesday, December 1, 2009 ,, Time:...
(Date:11/20/2009)...ire-USNewswire/ -- The US government reported Mond...ough food to eat. This startling statistic highli...dly aging into poverty. "Forced retirements, layo...y have incomes that no longer cover the basic expe...re particularly vulnerable," said Kate White Execu...
Breaking Medicine News(10 mins):Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:High blood pressure easy to miss in children with kidney disease 2Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...RNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE:,M...o the global life,sciences markets, today announce...ed (AECL) with notice of arbitration proceedings. ...f not,granted, seeking significant monetary damage...
...adds to its unparalleled content on breastfeeding ...professional articles on child, health, from aller...king., BOULDER, Colo., July 9 Breastfeeding.com,...,professional articles on infant, toddler, and chi...
... DRE, Inc., a premier international surgic...tomers that as much as $250,000 in medical equipme...filings. , Louisville, KY...ent bought in 2008. This could make 2008 an attrac...
... This first-of-its-kind Diamond Elite Wal...to graze, chip or develop cracks. , ...ter two years in development, The Kitchen Bath Sto...w 1-inch-high entry and is 3-times thicker and str...
... InsuranceSpecialists.com, a leader in onl... a decade, now offers comprehensive information to...candidates are taking on health reform as election...mers make the best choices in coverage for themsel...
... The International Health and Fitness Symp...d-renowned physicians, best-selling authors and li...e to Health, Happiness and Longevity. The Internat...e-of-a-kind event to share their knowledge --and s...
Other Medicine News:Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 2Health News:MDS Commences Arbitration against AECL over Cancelled MAPLE Project and Files $1.6 Billion Court Claim against AECL and the Government of Canada 3Health News:Breastfeeding.com Becomes a Premier Resource on Child Health 2Health News:Economic Stimulus Act Can Improve Medical Equipment Purchasing Power 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The International Health and Fitness Symposium Releases The People's Guide to Health, Happiness and Longevity 2Health News:The International Health and Fitness Symposium Releases The People's Guide to Health, Happiness and Longevity 3Health News:The International Health and Fitness Symposium Releases The People's Guide to Health, Happiness and Longevity 4
(Date:11/20/2009)... Nov. 20 ,, Reportlinker.com an...able in its catalogue. ,, Global Markets for B...rtlinker.com/p0164741/Global-Markets-for-Breast-Bi...tm_medium=pr&utm_campaign=prnewswire ,, T...es the spring loaded core needle market and vacuum...
(Date:11/20/2009)...v. 20 Cyberonics, Inc. (...esident and Chief Executive Officer, and Greg Brow...1st Annual Piper Jaffray Health Care Conference in...PM EST. The conference session and webcast will b...d. Piper Jaffray will host a webcast of the prese...
(Date:11/19/2009)...d, Nov. 19 Warner Chilcott plc (Na...reviously announced secondary offering of 20,000,0... of $22.25 per share. The selling shareholders in... DLJ Merchant Banking, J.P. Morgan Partners (advis...P., certain other institutional investors and memb...
Breaking Medicine Technology:Reportlinker Adds Global Markets for Breast Biopsy Devices 2009 2Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4First CyberKnife System Installed in Canada 57379 1First CyberKnife System Installed in Canada 57379 2First CyberKnife System Installed in Canada 57379 3First CyberKnife System Installed in Canada 57379 4GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited 57375 1GENova Biotherapeutics signs engagement agreement with PacificWave Partners Limited 57375 2Introducing Sore Throat Relief Parents Trust in a Form that Fizzles 21 57371 1Introducing Sore Throat Relief Parents Trust in a Form that Fizzles 21 57371 2
...ht Pre-clinical Work of Company,s Future Pro-heali...usNeich announced today that two year follow up da... in patients at high risk of restenosis were prese... in patients treated with the company,s Genous Bio... stent, compared with results from patients treate...
...any, May 20 Miltenyi Biotec,announces the worldwi...Myelin,is a specialized membrane which ensheathes ...nervous system. During preparation of single-cell,...he major contaminant. "When,dissociating adult neu...l,suspension consists of cells. The rest correspon...
Other Medicine Technology:Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents 2Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Compared to Drug-Eluting Stents 3Myelin Removal Beads: Premium Efficiency for Neural Cell Separations and Antibody Stainings 2
Head-worn Loupes LC
Head-worn Loupe G3
...ion for advanced surgical procedures. Prismatic qu...highest magnification. 3.5x, 4.5x and 5.5x. Edge t...l for surgical applications. Precision lenses trea...rior image. The compact abd lightweight design pro...
XL Advantage Prismatic
Medicine Products: